RB1 loss triggers dependence on ESRRG in retinoblastoma

Matthew G. Field, Jeffim N. Kuznetsoff, Michelle G. Zhang, James J. Dollar, Michael A. Durante, Yoseph Sayegh, Christina L. Decatur, Stefan Kurtenbach, Daniel Pelaez, J. William Harbour

Research output: Contribution to journalArticlepeer-review

Abstract

Retinoblastoma (Rb) is a deadly childhood eye cancer that is classically initiated by inactivation of the RB1 tumor suppressor. Clinical management continues to rely on nonspecific chemotherapeutic agents that are associated with treatment resistance and toxicity. Here, we analyzed 103 whole exomes, 20 whole transcriptomes, 5 single-cell transcriptomes, and 4 whole genomes from primary Rb tumors to identify previously unknown Rb dependencies. Several recurrent genomic aberrations implicate estrogen-related receptor gamma (ESRRG) in Rb pathogenesis. RB1 directly interacts with and inhibits ESRRG, and RB1 loss uncouples ESRRG from negative regulation. ESRRG regulates genes involved in retinogenesis and oxygen metabolism in Rb cells. ESRRG is preferentially expressed in hypoxic Rb cells in vivo. Depletion or inhibition of ESRRG causes marked Rb cell death, which is exacerbated in hypoxia. These findings reveal a previously unidentified dependency of Rb cells on ESRRG, and they implicate ESRRG as a potential therapeutic vulnerability in Rb.

Original languageEnglish (US)
Pages (from-to)eabm8466
JournalScience Advances
Volume8
Issue number33
DOIs
StatePublished - Aug 19 2022

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'RB1 loss triggers dependence on ESRRG in retinoblastoma'. Together they form a unique fingerprint.

Cite this